On May 31, the Ministry of Health of Ukraine registered a European-made AstraZeneca vaccine against COVID-19 for emergency medical use, according to the agency’s website.
The vaccine, developed by Oxford University and the British-Swedish company AstraZeneca, is reportedly manufactured in Italy and has the trade name AstraZeneca. The AstraZeneca emergency vaccine has already been approved by the World Health Organization and has also been approved by the UK, EU, India and Canada.
By the end of the week, within the framework of the global COVAX initiative, 705,600 doses of the AstraZeneca vaccine will arrive in Ukraine. It will be intended for vaccination with a second dose of those who have already passed the 12-week interval after the first vaccination, in particular, doctors and healthcare workers, JFO participants, social workers, clergymen, employees of the Ministry of Internal Affairs, the Security Service of Ukraine, persons aged 65+. Also, the second dose of the vaccine is guaranteed to people who were vaccinated with residual doses or public figures.
AstraZeneca, COVID-19, HEALTH MINISTRY, VACCINE
